Purchase Order 75N93024P01059
Award Date
8/27/24
Potential Completion Date
11/30/24
Potential Value
$19K
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
A&G Pharmaceutical, Inc.
Ultimate Awardee
Not listed
NAICS Category
541380 - Testing Laboratories and Services
PSC Category
Q301 - Reference Laboratory Testing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Columbia, MD 21045, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Department of Health and Human Services (HHS), through the National Institute of Allergy and Infectious Diseases (NIAID), awarded a $5,286.50 firm-fixed-price purchase order to A&G Pharmaceutical, Inc. (doing business as Precision Antibody) for custom antibody generation services. The award, with a completion date of December 18, 2013, is not associated with a set-aside designation. Precision Antibody is a for-profit manufacturer of goods specializing in custom antibody...
This is a $5,820 firm-fixed price purchase order awarded by the National Institutes of Health (NIH) to A&G Pharmaceutical, Inc. (doing business as Precision Antibody) for monoclonal antibody production services. The contract is not set-aside and was awarded under the NIH's Acquisition Operations. Precision Antibody is a for-profit manufacturer of specialized biological materials and services, including custom antibody development, cell lines, and peptide synthesis, in support of biomedical...
This firm-fixed price purchase order was awarded to A&G Pharmaceutical, Inc. (doing business as Precision Antibody) by the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services. The $7,951.40 award is for the delivery of custom antibody development services including monoclonal antibodies, cell lines, labeled antibodies, polyclonal antibodies, and peptide synthesis. These...
This $13,670 federal contract was awarded by the National Institutes of Health (NIH) to A&G Pharmaceutical, Inc., doing business as Precision Antibody, a for-profit manufacturer of custom antibodies and related products for biomedical research. The contract was issued as a purchase order for the delivery of custom antibodies. Precision Antibody has a strong track record of federal contract awards, primarily from NIH institutes, for providing specialized biological materials and services to...
This firm-fixed price purchase order was awarded by the Food and Drug Administration (FDA), a civilian agency within the U.S. Department of Health and Human Services (HHS), to A&G Pharmaceutical, Inc., doing business as Precision Antibody. The $9,750 contract is for the delivery of monoclonal antibodies. Precision Antibody is a for-profit manufacturer of goods that specializes in custom antibody development services to support biomedical research. The company has an extensive history of...
The Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences awarded a $132,862.50 firm fixed price delivery order contract to A&G Pharmaceutical, Inc., doing business as Precision Antibody, to support the agency's research efforts. Under the contract, TO6 - GENERATING MONOCLONAL CELL LINES, MONOCLONAL ANTIBODIES, AND LABELED MONOCLONAL ANTIBODIES AGAINST HUMAN AND MOUSE COLQ, Precision Antibody will provide monoclonal cell...
This federal contract award, identified by the ID HHSF223201011747P, was issued by the Food and Drug Administration (FDA) to A&G Pharmaceutical, Inc., doing business as Precision Antibody. The $8,245 firm-fixed-price purchase order is for precision antibody services, including custom monoclonal and polyclonal antibody development, cell line generation, and specialized laboratory testing. The contract is part of a larger $100 million Blanket Purchase Agreement (BPA) awarded by the National...
This federal contract was awarded by the National Cancer Institute, a component of the National Institutes of Health (NIH), to A&G Pharmaceutical, Inc. (doing business as Precision Antibody) for a COVID-19-related project analyzing a novel truncated form of the ACE2 receptor. The $19,349.65 firm-fixed-price purchase order was awarded on June 18, 2020, with a period of performance through June 19, 2020. The contract was awarded without any set-aside designation, indicating open competition....
The U.S. Department of Health and Human Services, National Institutes of Health, National Center for Advancing Translational Sciences awarded a firm-fixed price delivery order contract to A&G Pharmaceutical, Inc., doing business as Precision Antibody, to generate drug-specific monoclonal antibodies against TTHX1114, an engineered mutant human FGF1. The $50,208.55 contract has a completion date of June 30, 2020 and does not have a set-aside designation. Precision Antibody is a for-profit...
This is a firm fixed-price Blanket Purchase Agreement (BPA) awarded by the National Institutes of Health (NIH) Office of Logistics and Acquisition Operations to A&G Pharmaceutical, Inc., doing business as Precision Antibody. The $100 million BPA, with ID 75N98024A00057, enables the ordering of biological materials, laboratory and testing services, and animal testing services in support of biomedical research through January 31, 2025. The BPA allows various NIH institutes, as well as the U.S....